StockSelector.com
  Research, Select, & Monitor Tuesday, October 16, 2018 7:42:52 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Biogen Inc.$328.41($2.53)(.76%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Biogen Inc. vs Biotechnology

IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. Their first commercial product, Rituxan, and our most advanced product candidate, ZEVALIN, are for use in the treatment of certain B-cell non-Hodgkin's lymphomas. They are also developing products for the treatment of various autoimmune diseases (such as psoriasis, rheumatoid arthritis and lupus).




An exciting industry consisting of companies who develop new drugs to combat such diseases as cancer and other life-threatening diseases. Some may also participate in gene therapy. These firms either bring new drugs to the market themselves (which is a grueling process) or they sell their technology to bigger pharmaceutical companies.
 Totals Company Industry
  Sales: $12,273.9 Mil $93,638.5 Mil
  Market Cap: $68,079.4 Mil $489,714.7 Mil
  Analysts Recommendation: Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: 7.2% 45.3%
  Estimated Revenue: 7.5% 103.7%
  Historic Earnings: 7.9% (35.9%)
  Estimated Earnings: 13.0% 6.6%
  Stock Price (1 Year): (2.7%) 22.6%
  Cash per Share: (30.9%) 19.1%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: 12.0 28.5
  Price-to-Sales: 5.5 N/A
  Price-to-Book: 5.5 4.3
  Dividend Yield: N/A N/A
  Market Cap: $68,079.4 Mil $10,646.0 Mil
  Operations
  Net Margin: 20.7% (972.3%)
  Gross Margin: 86.7% 74.9%
  Return on Equity: .2 (.3)
  Return on Assets: .1 (.3)
  Balance Sheet
  Current Ratio: 2.3 5.1
  Quick Ratio: 2.1 4.7
  Cash Ratio: 1.1 4.0
  Debt-to-Equity: .9 1.0
  Interest Coverage: N/A 1.7
 Technicals
  Relative-Strength Index: 36.2 46.1

 Other companies in Biotechnology Price Market Cap
  Amgen, Inc.  (AMGN) $195.59 $129,089.4 Mil
  Gilead Sciences, Inc.  (GILD) $72.78 $95,196.2 Mil
  Celgene Corp.  (CELG) $81.83 $59,948.7 Mil
  Regeneron Pharmaceuticals Inc.  (REGN) $377.55 $43,220.8 Mil
  Incyte Corp.  (INCY) $62.03 $13,342.8 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.